Following the integrated clinical strategy of cardiac-cerebral co-management and interventional prophylaxis against stroke, the company provides a full solution portfolio for atrial fibrillation, consisting of the C-Clip® Left Atrial Appendage (LAA) Closure System, Fidus® LAA Occluder, and surgical radiofrequency ablation systems.
